Article and Video CATEGORIES
2023 Terapias Dirigidas en el Foro de Pacientes con Cáncer de Pulmón
El vídeo completo sin editar está disponible On Demand
AGENDA del Foro de Terapias Dirigidas en Pacientes con Cáncer de Pulmón 2023 Spanish 2023 Targeted Therapies in Lung Cancer Patient Forum AGENDAPresidente del evento / Event Chair Luis Raez, MD
|
Available DownloadableDocuments
|
|
9:00 AM
|
Bienvendia y Palabras de Apertura / Welcome and Opening Remarks Event Chair: Dr. Luis Raez
|
|
9:10 AM
9:55 AM
10:25 AM
10:55 AM
|
Discusion del Panel: Presentaciones de Casos con Mutaciones EGFR y Resistencia Panel Discussion: Presentation of Cases with EGFR Mutation and Resistance Cases/moderator: Dr. Fernando Diaz, Panel: Alberto Chiappori, Luis Corrales, Estelamari Rodriguez
Desafíos en el Diagnóstico Molecular y el Papel Que Juegan las Biopsias Líquidas Challenges in Molecular Diagnostics and the Role of Liquid Biopsies Dr. Luis Raez
Terapias Dirigidas para Tumores KRAS Targeted Therapies for KRAS+ Tumors Dr. Luis Corrales
Terapias Dirigidas Para NSCLC Temprana Targeted Therapies for Early NSCLC Dr. Estelamari Rodriguez |
Download Slides: Discusion del Panel: Presentaciones de Casos con Mutaciones EGFR y Resistencia
Download Slides: Desafíos en el Diagnóstico Molecular y el Papel Que Juegan las Biopsias Líquidas
Download Slides: Terapias Dirigidas para Tumores KRAS
Download Slides: Terapias Dirigidas Para NSCLC Temprana
|
11:25 AM
|
Panel y Q&A Panel and Q&A Dr. Luis Raez (moderator), Diaz, Corrales, Chiappori, Rodriguez |
|
11:45 AM |
Mensaje de Agradecimiento y Despedida / Thank you and Closing Event Chair: Dr. Luis Raez |
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi Stan,
It's so good to hear you and yours are doing well and that you were able to spend time with both families for Thanksgiving. I know it meant a...
Hi Stan! It is good to hear from you -- I am so very happy you are doing well. I agree with Janine that family and friends - our chosen family...
Recent Comments
I understand…